Additionally, AIM2 activation triggered the release of caspase-4 from IPF-derived PBMCs, which corresponded to higher mRNA levels of this caspase in IPF PBMCs compared to healthy ones [55]. The gene discussed is CASP4; the disease is idiopathic pulmonary fibrosis.